Schroder Investment Management Group
KALV

Schroder Investment Management Group’s KalVista Pharmaceuticals KALV Stock Holding History

Schroder Investment Management Group’s Portfolio KALV Stock Details KALV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-506,743
Closed -$9.3M – 1212
2026
Q1 		$9.3M Sell
506,743
-665,012
-57% -$10.7M 0.01% 686
2025
Q4 		$18.9M Buy
1,171,755
+13,298
+1% +$176K 0.01% 524
2025
Q3 		$14.1M Buy
1,158,457
+603,499
+109% +$8.34M 0.01% 598
2025
Q2 		$6.27M Sell
554,958
-313,053
-36% -$3.83M 0.01% 730
2025
Q1 		$10.4M Buy
868,011
+62,566
+8% +$639K 0.01% 634
2024
Q4 		$6.76M Buy
805,445
+374,213
+87% +$3.88M 0.01% 719
2024
Q3 		$5.32M Sell
431,232
-36,766
-8% -$462K 0.01% 775
2024
Q2 		$5.51M Buy
467,998
+213,224
+84% +$2.49M 0.01% 761
2024
Q1 		$3.02M Buy
+254,774
New +$3.4M ﹤0.01% 866

Other funds holding KALV

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Schroder Investment Management Group's KALV Position: Q2 2026 in Review

Schroder Investment Management Group sold out of KalVista Pharmaceuticals (KALV) in Q2 2026, closing a stake of 506,743 shares — an estimated $9.3M sold.

Schroder Investment Management Group first reported a position in KALV in Q1 2024 and held it in 9 quarters. The position peaked at $18.9M in Q4 2025. 1 fund tracked by Wall St. Rank holds KALV as of Q2 2026.

  • Schroder Investment Management Group reported no remaining KalVista Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Schroder Investment Management Group sold 506,743 KalVista Pharmaceuticals shares in Q2 2026, an estimated $9.3M.
  • Schroder Investment Management Group first reported a position in KalVista Pharmaceuticals in Q1 2024 and held it in 9 quarters.
  • Schroder Investment Management Group's KalVista Pharmaceuticals position peaked at $18.9M in Q4 2025.
  • 1 fund tracked by Wall St. Rank held KalVista Pharmaceuticals as of Q2 2026.

Based on Schroder Investment Management Group's 13F filing for Q2 2026, filed 13 Aug 2026.